ESC 365 - PFO closure for cryptogenic stroke – Represented in NEJM by the CLOSURE I, PC, REDUCE, CLOSE, and RESPECT trials

ESC Premium Access

PFO closure for cryptogenic stroke – Represented in NEJM by the CLOSURE I, PC, REDUCE, CLOSE, and RESPECT trials

Session: Highlights from the New England Journal of Medicine: Editors’ Choice

Topic: Coronary Artery Disease (Chronic) / Chronic Coronary Syndromes (CCS)

Speaker: Professor L. Sondergaard (Copenhagen, DK)

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Professor Lars Sondergaard

Rigshospitalet - Copenhagen University Hospital, Copenhagen (Denmark)

15 presentations

2 followers

3 more presentations in this session

Antithrombotic therapy in stable cardiovascular disease - Represented in NEJM by the COMPASS trial and the PEGASUS-TIMI 54 trial

Speaker: Doctor J. Eikelboom (Hamilton, CA)

Antithrombotic therapy in patients with atrial fibrillation undergoing PCI – Represented in NEJM by the PIONEER-AF PCI trial and the RE-DUAL PCI trial

Speaker: Professor C. Cannon (Boston, US)

Fractional Flow Reserve-Guided PCI – represented in NEJM by the FAME, FAME-2, Compare-Acute, IFR-SWEDEHEART, and DEFINE-FLAIR trials

Speaker: Professor E. Barbato (Rome, IT)

Access the full session

Highlights from the New England Journal of Medicine: Editors’ Choice

Speakers: Professor L. Sondergaard, Doctor J. Eikelboom, Professor C. Cannon, Professor E. Barbato

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources